2026-10-08
Bloomberg
7 related
Sources: London-based Isomorphic Labs, an AI drug discovery startup spun out of Google DeepMind, is in early talks to raise funds at a $40B to $50B valuation
Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.'s Google DeepMind, is in early talks to raise new funds …
2026-05-13
Reuters
18 related
Isomorphic Labs, an AI-powered drug discovery spinoff from Google DeepMind, raised $2.1B led by Thrive, after raising $600M in its first round in March 2025
Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion …
2026-05-12
Reuters
15 related
Isomorphic Labs, an AI-powered drug discovery spinoff from Google DeepMind, raised $2.1B led by Thrive, after raising $600M in its first round in March 2025
Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion …
2025-03-31
New York Times
10 related
Isomorphic Labs, a DeepMind spinoff focusing on drug discovery, raised $600M led by Thrive to research treatments, including for cancer and immune disorders
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer.
2024-10-16
The Information
3 related
UK filings: Google DeepMind's 2023 operating profit rose 91% YoY to £136M, after the Google Brain merger; Alphabet's Isomorphic Labs loss rose 3x+ YoY to £60.4M
Jon Victor / The Information :
Loading articles...